Newlink Genetics reported $106.46M in Assets for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Bristol Myers Squibb BMY:US $ 110893M 96M
Capricor Therapeutics CAPR:US $ 43.1M 3.17M
Celldex Therapeutics CLDX:US $ 460.2M 255.65M
Eli Lilly And LLY:US $ 48187M 378M
Idera Pharmaceuticals IDRA:US $ 39.18M 5.23M
Intrexon XON:US $ 376.9M 25.67M
Nektar Therapeutics NKTR:US $ 1277.24M 94.11M
Newlink Genetics NLNK:US $ 106.46M 7.8M
Prothena PRTA:US $ 632.7M 196.33M
Sarepta Therapeutics SRPT:US $ 2662.22M 96.86M
Vascular Biogenics VBLT:US 61.14M 6.2M
YTE INCY:US $ 4198.83M 294.21M